Table 1.
Serum PON1 IC50 (µM) | % Inhibition of serum PON1d | |||||
---|---|---|---|---|---|---|
Name of compound | Paraoxona | Phenylacetateb | Purified PON1 IC50 (µM)c | Paraoxona | Phenylacetateb | % Inhibition of purified PON1d |
Naringenin | 37.9 | 34.6 | 10 | 25 | 32 | 50 |
2‐HQ | 1.8 | 1.4 | <1 | 89 | 92 | 94 |
2‐HQ, 2‐hydroxyquinoline.
aFor the assay of paraoxonase activity.
bFor the assay of arylesterase activity.
cIC50 values were determined by arylesterase activity.
dNaringenin and 2‐HQ were used at concentrations of 10 and 5 µM, respectively.